Latest DEF 14A proxy statements

Syra Health Corp. announced its 2025 Annual Meeting of Stockholders to elect directors, ratify auditors, and vote on amendments to Class B Common Stock conversion and transfer rules.

Intelligent Bio Solutions Inc. will hold its Annual Meeting on October 16, 2025, seeking stockholder approval for director elections, auditor ratification, an increase in its long-term incentive plan shares, the issuance of shares from a warrant exercise inducement, and a potential reverse stock split.

Heron Therapeutics is seeking shareholder approval for the potential issuance of common stock exceeding 19.99% of current outstanding shares, stemming from the conversion of convertible senior unsecured promissory notes and Series A Convertible Preferred Stock.

Greene County Bancorp, Inc. announced its annual shareholder meeting for November 1, 2025, to vote on director elections, auditor ratification, and executive compensation.

BIO-TECHNE Corporation has filed definitive additional proxy soliciting materials with the U.S. Securities and Exchange Commission.

Jefferies Financial Group and Sumitomo Mitsui Banking Corporation significantly expand their global strategic alliance, increasing SMBC's equity ownership to 20% and providing $2.5 billion in new credit facilities.

Greene County Bancorp, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and executive compensation matters.

Anteris Technologies Global Corp. adjourned its Special Meeting of Stockholders to September 29, 2025, after failing to achieve a quorum for key proposals, including an ASX waiver for issuing new securities.

Parker-Hannifin Corporation's definitive proxy statement highlights record fiscal year 2025 financial results, strong corporate governance, and executive compensation aligned with performance.

Bio-Techne Corporation reported 5% organic revenue growth and $1.2 billion in revenue for fiscal year 2025, alongside strategic portfolio adjustments and enhanced governance practices.

LSI Industries Inc. has filed a Definitive Proxy Statement with the SEC, indicating upcoming shareholder matters.

LSI Industries announces its 2025 Annual Meeting of Shareholders, detailing director elections, auditor ratification, and executive compensation, following a year of robust sales growth and increased Adjusted EBITDA.

Augusta Gold Corp. shareholders are invited to vote on a proposed merger with AngloGold Ashanti (U.S.A.) Holdings Inc. for C$1.70 cash per share, unanimously recommended by Augusta Gold's board.

Tesla, Inc. has updated its website and social media with additional materials related to its 2025 Annual Meeting of Shareholders, urging investors to review the Definitive Proxy Statement.

Tenon Medical, Inc. announced its adjourned Annual Meeting will be held virtually on September 18, 2025, to vote on director elections, warrant exercisability, and an equity plan amendment.

Priority Income Fund, Inc. has filed its definitive proxy statement (DEFA14A) with the SEC, a standard regulatory disclosure.

Prospect Capital Corporation has filed definitive additional materials related to a proxy statement with the SEC.

NovaBay Pharmaceuticals provided important details regarding its $0.80 per share special cash dividend and announced the record and meeting dates for its 2025 Annual Meeting of Stockholders.

Abpro Holdings, Inc. has adjourned its 2025 Annual Meeting of Stockholders until October 10, 2025, to allow more time to solicit votes and achieve a quorum.

GameSquare Holdings Inc. has engaged Laurel Hill Advisory Group, LLC to assist in soliciting proxies for its upcoming annual meeting on October 7, 2025.

The Hain Celestial Group, Inc. announced its 2025 Annual Meeting of Shareholders to vote on director elections, executive compensation, auditor ratification, and a stock award plan amendment.

FOXO Technologies intends to execute a reverse stock split to boost its stock price and attract institutional investors.

Alpha and Omega Semiconductor Limited has filed its definitive proxy statement with the SEC.

Tharimmune, Inc. calls a special meeting to vote on increasing authorized common stock, expanding its equity incentive plan, and authorizing future non-public offerings to support growth and capital needs.

Priority Income Fund, Inc. will hold its 2025 Annual Meeting to elect a director and approve a charter amendment to facilitate a potential national securities exchange listing by December 31, 2026, which includes a 270-day post-listing transfer restriction on common stock.

Prospect Capital Corporation announces its 2025 Annual Meeting of Stockholders to be held virtually on December 16, 2025, to elect two Class III directors and address other business.

Lifecore Biomedical, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on October 29, 2025, addressing director elections, auditor ratification, and executive compensation.

StableX Technologies, Inc. calls a special meeting to approve a $7 million private placement and an increase in its long-term incentive plan shares.

Hain Celestial Group announces a challenging fiscal year 2025 with missed financial targets, resulting in no executive incentive payouts, and outlines key proposals for its upcoming 2025 Annual Meeting.

GLIDELOGIC CORP. announced the postponement of its Annual Meeting of Stockholders to October 27, 2025, while the record date remains September 1, 2025.